Seth Sheldon is a Cardiology physician affiliated with University of Kansas. OpenAlex indexes 152 publications with 787 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4000 Cambridge Street Ste G600
Kansas City, KS 661608501
Telephone
913-588-9600Registry record last updated 18 Dec 2018.
Clinical trials
- Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation
Sponsor: University of Kansas Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202517 payments
- Biosense Webster, Inc.Program year20255 payments
- Abbott LaboratoriesProgram year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.4%Beta blocker24.8%Metoprolol Succinate63%Carvedilol16%Metoprolol Tartrate10%Sotalol9%Nebivolol Hcl2%Part D<11 patientsAntiarrhythmic18.7%Flecainide Acetate41%Dofetilide26%Mexiletine Hcl18%Amiodarone Hcl9%Multaq7%Part D≥60 patients+ 10 more classes in this area
Blood & clotting
27.5%Factor Xa inhibitor26.4%Eliquis69%Xarelto30%Savaysa2%Part D<11 patientsLow Molecular Weight Heparin0.7%Enoxaparin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.2%Proton pump inhibitor1.7%Pantoprazole Sodium100%Part D≥33 patientsPotassium supplement1.5%Potassium Chloride100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Characteristics of Patients With the Arrhythmogenic Mitral Valve Prolapse Syndrome and Sudden Cardiac Arrest and Sustained Ventricular Arrhythmias
Circulation Arrhythmia and Electrophysiology
2025 - Learning Curve for Left Bundle Branch Area Pacing Lead Implantation
Journal of Innovations in Cardiac Rhythm Management
2025 - Sequential Isolation of Persistent Left Superior Vena Cava and Right Superior Vena Cava Using Pulsed-field Ablation with a Pentaspline Catheter for Recurrent Persistent Atrial Fibrillation
Journal of Innovations in Cardiac Rhythm Management
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Simari, MD
University of Kansas
Tara Lin, MD
University of Kansas
Diane Cibrik, MD
University of Kansas
Martin Mainster, MD
University of Kansas
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”